SHL closes acquisition of almeda and will recognize in 2013 an operating profit of 5-7 M$ from the transaction. Will contribute yearly revenues of 7 to 10 M$ Donnerstag, 02. Januar 2014 - 07:03
| Press release |
| Press release (PDF) |
|
SHL closes acquisition of almeda and will recognize in 2013 an operating profit of 5-7 M$ from the transaction. Will contribute yearly revenues of 7 to 10 M$ |
|
Tel Aviv/Zurich, 2 January, 2014 - SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN), a leading provider and developer of advanced personal telemedicine solutions, announced today that it has closed the acquisition of almeda GmbH on December 31, 2013, through its wholly owned German subsidiary, SHL Telemedizin GmbH. SHL had announced the transaction in July 2013. With this acquisition, SHL expands its offering and advances its mission of being the leading provider of telehealth services in Germany. Upon completion of the transaction, effective for the financial results of the 4th quarter 2013, SHL will record a gain in its operating profit, expected to be between USD 5 to 7 million. The profit stems mainly from an agreement to provide products and services that was signed in parallel with the closing of the transaction to acquire almeda. almeda's telehealth business services patients of various well known Healthcare Insurers. It provides telehealth services to indications such as Congestive Heart Failure, COPD, diabetes and various other diseases and medical helpline services. DKV, the largest customer of the almeda telehealth business and one of the largest German private health insurers and a subsidiary of ERGO, committed to retain the provision of almeda’s telehealth services for a 7 year period. almeda’s telehealth business will contribute USD 7 to 10 million to SHL’s revenues as of 1 January, 2014. |
|
About SHL Telemedicine SHL Telemedicine Ltd. specializes in developing and marketing advanced personal telemedicine systems as well as providing comprehensive telemedicine solutions including medical call centers to individuals and to the healthcare community. As a leading provider of remote health services in cardiology and in other medical areas, SHL maintains business operations in Europe, mainly in Germany, and at its home market in Israel. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957). More information available at: http://www.shl-telemedicine.com/ For further information please contact:
Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements. |